Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001455244-10-000093)

Filing Details

Accession Number:: 0001455244-10-000093
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-07 13:00:00
Reporting Period:: 2010-04-05

Filing Date:: 2010-04-07
Accepted Time:: 2010-04-07 18:17:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Nabi Biopharmaceuticals	NABI	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1428524	D. Paul Kessler	C/O Nabi Biopharmaceuticals 12276 Wilkins Ave Rockville MD 20852	Svp Clinical, Med. & Reg.; Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-04-05	200	$5.30	118,300	No	4	S	Direct
Common Stock	Disposition	2010-04-05	928	$5.31	117,372	No	4	S	Direct
Common Stock	Disposition	2010-04-05	1,520	$5.32	115,852	No	4	S	Direct
Common Stock	Disposition	2010-04-05	700	$5.34	115,152	No	4	S	Direct
Common Stock	Disposition	2010-04-05	200	$5.36	114,952	No	4	S	Direct
Common Stock	Disposition	2010-04-05	500	$5.37	114,452	No	4	S	Direct
Common Stock	Disposition	2010-04-05	600	$5.38	113,852	No	4	S	Direct
Common Stock	Disposition	2010-04-05	600	$5.39	113,252	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.